6
DVLA0303.TXT

DVLA
Darya-Varia Laboratoria Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Mar-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 3

Summary of Balance Sheet
  Receivables               :     118,197,210.00
  Inventories               :      38,685,044.00
  Current Assets            :     217,518,462.00
  Fixed Assets              :      98,025,708.00
  Other Asstes              :          79,000.00
  Total Assets              :     361,587,752.00
  Current Liabilities       :      98,971,046.00
  Longterm Liabiities       :      14,861,610.00
  Total Liabilities         :     113,832,656.00
  Authorized                :         560,000.00
  Paid-up Capital           :     280,000,000.00
  Par Value                 :                500
  Paid-up Capital Shares    :         560,000.00
  Retained Earnings         :    -110,377,792.00
  Total Equity              :     247,755,096.00
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :     114,301,368.00
  Cost of Good Sold         :      39,173,463.00
  Gross Profit              :      75,127,905.00
  Operating Profit          :      32,840,114.00
  Other Income              :      -2,960,611.00
  Eearning Before Tax       :      29,879,503.00
  Tax                       :       9,209,681.00
  Net Income                :      20,669,822.00
  Closing Price             :             650.00

Per Share Data (Rp)
  Eps                       :             147.64
  Book Value                :             442.42

Financial Ratios
  Debt Equity Ratio (X)     :                .46
  Roa (%)                   :              22.87
  Roe (%)                   :              33.37
  Npm (%)                   :              72.33
  Opm (%)                   :             114.92

Cash Flow
  CF from Operating Activities                        :       5,548,857.00
  CF from Investing Activities                        :      -2,262,201.00
  CF from Financing Activities                        :      -9,112,571.00
  Net Increase in Cash & Cash Equivalent              :      -5,825,915.00
  Cash & Cash Equivalent at The Beginning of The Year :      51,739,136.00
  Cash & Cash Equivalent at The End of The Year       :      45,897,897.00

 
 
 
